Evidence map›Paper›PMID 25453759›Full record

ArticleMolecular cell2014

The initial uridine of primary piRNAs does not create the tenth adenine that Is the hallmark of secondary piRNAs.

Wei Wang, Mayu Yoshikawa, Bo W Han, Natsuko Izumi, Yukihide Tomari, Zhiping Weng, Phillip D Zamore

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Insights in piRNA targeting rules.Wiley interdisciplinary reviews. RNA · 2023
    Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Wei WangRNA Therapeutics Institute, Howard Hughes Medical Institute, and Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Mayu YoshikawaInstitute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.
Bo W HanRNA Therapeutics Institute, Howard Hughes Medical Institute, and Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Natsuko IzumiInstitute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.
Yukihide TomariInstitute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan. Electronic address: tomari@iam.u-tokyo.ac.jp.
Zhiping WengProgram in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: zhiping.weng@umassmed.edu.
Phillip D ZamoreRNA Therapeutics Institute, Howard Hughes Medical Institute, and Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: phillip.zamore@umassmed.edu.
Howard Hughes Medical Institute · USThe University of Tokyo · JPUniversity of Massachusetts Chan Medical School · US

Funding

EDAC: ENCODE Data Analysis CenterU41HG007000 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WENG, ZHIPING · 2012 to 2016
$9.8M
Understanding the Mechanism of RNA InterferenceR37GM062862 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZAMORE, PHILLIP D · 2010 to 2019
$5.3M
Understanding microRNA Biogenesis and FunctionR01GM065236 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZAMORE, PHILLIP D · 2003 to 2014
$5.0M
Understanding the Mechanism of RNA Interference (RNAi)R01GM062862 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZAMORE, PHILLIP D · 2001 to 2009
$3.2M
NHGRI NIH HHS HG007000NHGRI NIH HHS U41 HG007000NIGMS NIH HHS GM62862NIGMS NIH HHS GM65236NIGMS NIH HHS R01 GM062862NIGMS NIH HHS R01 GM065236NIGMS NIH HHS R37 GM062862
6 · The paper itself

Abstract

PIWI-interacting RNAs (piRNAs) silence transposons in animal germ cells. PIWI proteins bind and amplify piRNAs via the "Ping-Pong" pathway. Because PIWI proteins cleave RNAs between target nucleotides t10 and t11-the nucleotides paired to piRNA guide positions g10 and g11-the first ten nucleotides of piRNAs participating in the Ping-Pong amplification cycle are complementary. Drosophila piRNAs bound to the PIWI protein Aubergine typically begin with uridine (1U), while piRNAs bound to Argonaute3, which are produced by Ping-Pong amplification, often have adenine at position 10 (10A). The Ping-Pong model proposes that the 10A is a consequence of 1U. We find that 10A is not caused by 1U. Instead, fly Aubergine as well as its homologs, Siwi in silkmoth and MILI in mice, have an intrinsic preference for adenine at the t1 position of their target RNAs; during Ping-Pong amplification, this t1A subsequently becomes the g10A of a piRNA bound to Argonaute3.

Indexed as

AdenineAnimalsArgonaute ProteinsBombyxDrosophila melanogasterDrosophila ProteinsMiceModels, GeneticMolecular Sequence DataPeptide Initiation FactorsRNA, Small InterferingUridineAdenineAGO3 protein, DrosophilaArgonaute Proteinsaub protein, DrosophilaDrosophila ProteinsPeptide Initiation FactorsPiwil2 protein, mousepiwi protein, DrosophilaRNA, Small InterferingUridine

Identifiers

PMID25453759
PMCPMC4337030
OpenAlexW2037699544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.